Praxis Precision Medicines, Inc. PRAX Q1 2026 earnings
Reported May 7, 2026 · Before market open
EPS-$3.20Beat by $0.38
Revenue estimate$100.0K
EPS estimate-$3.58
Next report
Aug 10, 2026 (In 1 week)Revenue estimate$1.3M
EPS estimate-$3.67
Financials
Q1 2026Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Praxis Precision Medicines, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Praxis Precision Medicines, Inc. report Q1 2026 earnings?
- Praxis Precision Medicines, Inc. (PRAX) reported Q1 2026 earnings on May 7, 2026 before market open.
- What were Praxis Precision Medicines, Inc.'s Q1 2026 revenue and EPS?
- Praxis Precision Medicines, Inc. reported eps of $-3.20 for Q1 2026.
- Did Praxis Precision Medicines, Inc. beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-3.58 by $0.38.
- How did Praxis Precision Medicines, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 2.7% from $-3.29.
- Where can I find Praxis Precision Medicines, Inc.'s Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001689548-26-000047) directly on SEC EDGAR. The filing index links above go to sec.gov.